Track the companies that matter to you. It's FREE! Click one of these fan favorites to get started: Apple; Google; Ford.



Why Sears Holdings, MannKind, and Synnex Tumbled Today

Don't let it get away!

Keep track of the stocks that matter to you.

Help yourself with the Fool's FREE and easy new watchlist service today.

Although we don't believe in timing the market or panicking over daily movements, we do like to keep an eye on market changes -- just in case they're material to our investing thesis.

After the upbeat economic data that we've seen recently, investors weren't prepared for today's relatively small gain in nonfarm payroll numbers in the December employment report. Bond yields plunged as investors suddenly started putting further Fed accommodation back on the table, and stocks generally gained ground, even though the Dow lost about eight points on the day. Still, Sears Holdings (NASDAQ: SHLD  ) , MannKind (NASDAQ: MNKD  ) , and Synnex (NYSE: SNX  ) were among the worst performers on the day, each falling double-digit percentages due to company-specific news.

Sears plunged 14% after the retailer reported downbeat numbers for its holiday quarter last night. The retailer said that domestic Sears stores saw comps fall 9.2%, with Kmart comps falling 5.7%, and overall companywide same-store sales falling 7.4%. Adding insult to injury, Moody's downgraded Sears' bond rating to Caa1, which could make it more difficult for Sears to get the future financing it may need at favorable terms. The dour results led many to conclude that Sears will have trouble recovering from its current malaise, although it's far from the first death sentence the retailer has received from overanxious analysts.

MannKind declined 16% after the company announced a tentative date for the coming review from the FDA advisory committee of its Afrezza inhaled medication for hyperglycemia. Given that today's news only sets a timeline rather than gives any actual results, today's drop makes little more sense than yesterday's advance. Investors have waited a long time for results; therefore, the FDA advisory review on April 1 will mark a welcome step of progress one way or the other for MannKind.

Synnex fell 11%. The company delivered solid results for its fiscal fourth quarter, but its current-quarter earnings guidance fell 8% to 12% short of what investors were projecting for the business-process outsourcing and services company. The big question facing Synnex is whether the acquisition of IBM's (NYSE: IBM  ) customer-care service unit will help it boost its long-term prospects enough to make today's drop look like a bargain opportunity. With Synnex looking for continued improvement in demand for information-technology services in the future, the answer to that question could well be yes.

Don't settle for less than the best
There's a huge difference between a good stock and a stock that can make you rich. The Motley Fool's chief investment officer has selected his No. 1 stock for 2014, and it's one of those stocks that could make you rich. You can find out which stock it is in the special free report: "The Motley Fool's Top Stock for 2014." Just click here to access the report and find out the name of this under-the-radar company.

Read/Post Comments (0) | Recommend This Article (2)

Comments from our Foolish Readers

Help us keep this a respectfully Foolish area! This is a place for our readers to discuss, debate, and learn more about the Foolish investing topic you read about above. Help us keep it clean and safe. If you believe a comment is abusive or otherwise violates our Fool's Rules, please report it via the Report this Comment Report this Comment icon found on every comment.

Be the first one to comment on this article.

Sponsored Links

Leaked: Apple's Next Smart Device
(Warning, it may shock you)
The secret is out... experts are predicting 458 million of these types of devices will be sold per year. 1 hyper-growth company stands to rake in maximum profit - and it's NOT Apple. Show me Apple's new smart gizmo!

DocumentId: 2791453, ~/Articles/ArticleHandler.aspx, 9/2/2015 3:25:39 PM

Report This Comment

Use this area to report a comment that you believe is in violation of the community guidelines. Our team will review the entry and take any appropriate action.

Sending report...

Dan Caplinger

Dan Caplinger has been a contract writer for the Motley Fool since 2006. As the Fool's Director of Investment Planning, Dan oversees much of the personal-finance and investment-planning content published daily on With a background as an estate-planning attorney and independent financial consultant, Dan's articles are based on more than 20 years of experience from all angles of the financial world.

Today's Market

updated Moments ago Sponsored by:
DOW 16,248.59 190.24 1.18%
S&P 500 1,932.42 18.57 0.97%
NASD 4,706.95 70.85 1.53%

Create My Watchlist

Go to My Watchlist

You don't seem to be following any stocks yet!

Better investing starts with a watchlist. Now you can create a personalized watchlist and get immediate access to the personalized information you need to make successful investing decisions.

Data delayed up to 5 minutes

Related Tickers

9/2/2015 3:09 PM
IBM $144.13 Up +1.45 +1.01%
International Busi… CAPS Rating: ****
MNKD $3.74 Up +0.03 +0.81%
MannKind Corp CAPS Rating: **
SHLD $26.60 Up +0.45 +1.72%
Sears Holdings CAPS Rating: *
SNX $77.25 Up +0.11 +0.14%
SYNNEX Corp CAPS Rating: *****